NanoViricides Net Debt To E B I T D A from 2010 to 2024
| NNVC Stock | USD 1.13 0.07 5.83% |
Net Debt To EBITDA | First Reported 2010-12-31 | Previous Quarter 0.94 | Current Value 1.22 | Quarterly Volatility 0.97509829 |
Check NanoViricides financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NanoViricides main balance sheet or income statement drivers, such as Interest Expense of 1 K, Other Operating Expenses of 7 M or Research Development of 4.2 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.77. NanoViricides financial statements analysis is a perfect complement when working with NanoViricides Valuation or Volatility modules.
NanoViricides | Net Debt To E B I T D A |
Latest NanoViricides' Net Debt To E B I T D A Growth Pattern
Below is the plot of the Net Debt To E B I T D A of NanoViricides over the last few years. It is a leverage ratio that indicates a company's ability to pay off its incurred debt. It compares a company’s net debt (total debt minus cash) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). NanoViricides' Net Debt To EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NanoViricides' overall financial position and show how it may be relating to other accounts over time.
| Net Debt To E B I T D A | 10 Years Trend |
|
Net Debt To E B I T D A |
| Timeline |
NanoViricides Net Debt To E B I T D A Regression Statistics
| Arithmetic Mean | 1.70 | |
| Geometric Mean | 1.42 | |
| Coefficient Of Variation | 57.46 | |
| Mean Deviation | 0.76 | |
| Median | 1.66 | |
| Standard Deviation | 0.98 | |
| Sample Variance | 0.95 | |
| Range | 3.357 | |
| R-Value | (0.31) | |
| Mean Square Error | 0.93 | |
| R-Squared | 0.1 | |
| Significance | 0.26 | |
| Slope | (0.07) | |
| Total Sum of Squares | 13.31 |
NanoViricides Net Debt To E B I T D A History
About NanoViricides Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include NanoViricides income statement, its balance sheet, and the statement of cash flows. NanoViricides investors use historical funamental indicators, such as NanoViricides's Net Debt To E B I T D A, to determine how well the company is positioned to perform in the future. Although NanoViricides investors may use each financial statement separately, they are all related. The changes in NanoViricides's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NanoViricides's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on NanoViricides Financial Statements. Understanding these patterns can help to make the right decision on long term investment in NanoViricides. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Debt To EBITDA | 0.94 | 1.22 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NanoViricides in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NanoViricides' short interest history, or implied volatility extrapolated from NanoViricides options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of NanoViricides Correlation against competitors. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for NanoViricides Stock analysis
When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is NanoViricides' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Return On Assets (0.36) | Return On Equity (0.58) |
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.